Since expression of SIGLEC1 is present on AMs, and blockade of SIGLEC1 ex vivo significantly reduced the SARS-CoV-2 infection, it would be intriguing to investigate if SIGLEC1 could promote virus infection in vivo, especially in the lung where AMs are abundant. The gene discussed is SIGLEC1; the disease is viral infectious disease.